icrn phw energy cse dte gobar times rwh csestore iep
Cancer

Science and Technology - Briefs

Issue Date: May 31, 2013
ENVIRONMENTAL SCIENCES Shield melts off

'It is strange that government promotes products which directly cause cancer'

Issue Date: May 10, 2013
How serious is the problem of tobacco consumption in India? Interviewee:  Pankaj Chaturvedi

Watch the clock

Issue Date: May 15, 2013
MOST heart attacks occur in the morning. Depression and suicidal thoughts peak in the middle of the night. Travelling across time zones makes people feel out of sorts. While these appear to be different observations, there is one interesting phenomenon common to them all: a clock that constantly ticks inside of us.

Testing the CL route

Issue Date: Mar 15, 2013
Last month I ran into Ecuador’s popular president Rafael Correa as he was campaigning for a third term—he has since been re-elected with a record majority—and recalled his path-breaking decision to issue compulsory licences (CLs) to ensure cheaper medicines for his expanding public health programme. The decree, the first such in Latin America, was issued in October 2009 for some much-needed drugs and, six months later, the Ecuadorian government handed out the first CL on US multinational Abbott’s ritonavir, an AIDS medication.

Novel Therapy

Issue Date: Mar 15, 2013
You suggest beta lactams, used in antibiotics, are effective anticancer drugs. How did this idea come to you? Interviewee:  Bimal K Banik

Science and Technology - Briefs

Issue Date: Mar 15, 2013
ATMOSPHERIC SCIENCES Making waves

world cancer day

world cancer day

Flashback

Issue Date: Feb 2, 2013
Zeroing in on carcinogens

Cancer research goes 3D

Author(s): Dinsa Sachan
Issue Date: Jan 15, 2013
CANCER is baffling. While certain types spread slowly over the years, others grow within weeks and months, leaving hardly any scope for survival. Understanding how cancer cells spread within the body is, therefore, important for developing new and improved drugs for the dreaded disease.

Strong medicine for weak drug patents

Issue Date: Nov 30, 2012
Two patents being nullified in quick succession may not add up to a trend. But in this season of revocations, patient groups and public health lobbies and, of course, the generic drug industry are sniffing the promise of a new spring in these decisions even though both can be challenged in different forums.
CSE WEBNET
Follow us ON
Follow grebbo on Twitter    Google Plus  DTE Youtube  rss